LakeShore Biopharma Co., Ltd

Market Cap

$3M

Healthcare·Biotechnology·🇺🇸 United States·NYSE

Healthcare·Biotechnology·🇺🇸·NYSE

Stock Price

$0.07-$0.77 (-92.02%)

Jun 22, 2026

52W High $1.3852W Low $0.03

Company Details

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventiona...

Leadership

Wang Xu

CEO & Director

Rui Yu M.B.A., M.S.

CFO & Director

Hui Shao C.F.A., M.B.A., Ph.D.

President, Chief Business Officer & Vice Chairman

Zhiyuan Ran

Head of Marketing and Sales

Yuan Liu Ph.D.

Head of Vaccine Research

Honggang Teng

Head of Production & Quality Management

IPO Date

—

Website

www.lakeshorebio.com

Key Metrics TTM (CNY)

Revenue

¥577M

+19.9% YoY

Net Income

-¥434M

EPS (Diluted)

Free Cash Flow

Revenue / Share

¥5.77

Gross Margin

67.4%

Operating Margin

-77.2%

Net Margin

-75.1%

FCF Margin

P/S

P/E

Revenue & Profitability (CNY)

Operating Cash Flow (CNY)

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (CNY)

OpEx Breakdown (CNY)

War Chest (CNY)

Shares Outstanding